DIAGNOSTICS-IMPACT ON THE PREMIUM CHANNEL - Heidelberg Engineering
-
Upload
healthegy -
Category
Health & Medicine
-
view
796 -
download
0
Transcript of DIAGNOSTICS-IMPACT ON THE PREMIUM CHANNEL - Heidelberg Engineering
Visionary Diagnostic Solutions
Kester Nahen, PhDManaging Director
SPECTRALIS Multimodal Imaging Platform
SPECTRALISWidefield OCT Module
SPECTRALIS Widefield OCT Module
55°30°
16,5 mm
SPECTRALIS Widefield OCT Module
Courtesy of Prof. Staurenghi, Milan
SPECTRALISMultiColor Module
MultiColor Imaging
View images of individual laser colors to gain better understanding of structural detail at different depths within the retina
Image courtesy of S. Wolf, MD, PhD, Bern, Switzerland
ERM, RNFL, macular pigment
blood vessels, blood, excudates
drusen, RPE, choroid
SPECTRALISWidefield Fundus Imaging Module
Widefield MultiColor Imaging
30°
55°
SPECTRALISOCT2 Module
Next generation OCT module
85 kHz A-scan rate
Scan time approx. cut in half
OCT2 scan speed improves workflow
OCT2 supports efficient workflow while performing dense volume scans Transverse Section Analysis (TSA)
Vitreoretinal interfaceRPEChoroid
OCT2 scan speed improves workflow
OCT-Angiography
OCT-Angiography - work in progress, not for sale
OCT2 scan speed improves workflow
OCT2 supports comprehensive scan protocols Glaucoma Module Premium Edition
Glaucoma Module Premium Edition is pending FDA approval
OCT2 image quality improves diagnostic potential
High image contrast vitreous to choroid
Reliable Multi-Layer Segmentation
OCT2
Foundation for Layer thickness analysis Transverse Section Analysis (TSA) OCT-Angiography
OCT-Angiography - work in progress, not for sale
GCL
OCT2 image quality improves diagnostic potential
Transverse Section Analysisof patient with drusen
OCT2 integrates with existing SPECTRALIS
OCT
OCT2
Analyses are fully compatible between both OCT generations
Ensures tracking progression over long periods of time using AutoRescan function and Active Eye Tracking
OCT2 integrates with existing SPECTRALIS
OCT
OCT2
SPEC
TRAL
IS
Analyses are fully compatible between both OCT generations
Ensures tracking progression over long periods of time using AutoRescan function and Active Eye Tracking
Makes the Spectralis a safe long term investment
SPECTRALISOCT-Angiography Module
OCT-Angiography is work in progress
Superficial Capillary Plexus
Depth-Selective Visualization of the Vascular Network
OCT-Angiography is work in progress
Superficial Capillary Plexus
Depth-Selective Visualization of the Vascular Network
OCT-Angiography is work in progress
Deep Capillary Plexus
Depth-Selective Visualization of the Vascular Network
OCT-Angiography is work in progress
Deep Capillary Plexus
Depth-Selective Visualization of the Vascular Network
OCT-Angiography is work in progress
Choriocapillaris
Depth-Selective Visualization of the Vascular Network
OCT-Angiography is work in progress
26
Sattler’s Layer
Depth-Selective Visualization of the Vascular Network
OCT-Angiography is work in progress
27
Haller’s Layer
Depth-Selective Visualization of the Vascular Network
OCT-Angiography is work in progress
CONFIDENTIAL 28
FA
BluePeak
ICGA
OCT Angio
OCT-Angiography is work in progress
SPECTRALISMultimodal
Imaging
CONFIDENTIAL 29
FA
BluePeak
ICGA
OCT Angio
SPECTRALISMultimodal
Imaging
OCT-Angiography is work in progress
CONFIDENTIAL 30
FA
BluePeak
ICGA
OCT Angio
OCT-Angiography is work in progress
SPECTRALISMultimodal
Imaging
CONFIDENTIAL 31
FA
BluePeak
ICGA
OCT Angio
SPECTRALISMultimodal
Imaging
OCT-Angiography is work in progress
CONFIDENTIAL 32
FA
BluePeak
ICGA
OCT Angio
OCT-Angiography is work in progress
SPECTRALISMultimodal
Imaging
CONFIDENTIAL 33
FA
BluePeak
ICGA
OCT Angio
SPECTRALISMultimodal
Imaging
OCT-Angiography is work in progress
CONFIDENTIAL 34
FA
BluePeak
ICGA
OCT Angio
OCT-Angiography is work in progress
SPECTRALISMultimodal
Imaging
SPECTRALIS – Expandable Imaging Platform
Explore New SPECTRALIS Modules Widefield OCT Widefield Fundus Imaging OCT2 OCT-Angiography
Enjoy Safe Investment SPECTRALIS systems purchased with Advanced
Upgrade Package or MultiColor module are upgradeable to OCT2
OCT-Angiography is work in progress
For 25 years Heidelberg Engineering has been providing solutions
to fundamental diagnostic challenges in ophthalmology.
With HRT and SPECTRALIS we have achieved this
for both glaucoma and retina.
The Cataract and Refractive Imaging Platform is currently under development and not for sale yet.
Now we intend to achieve the same for the current challenges in the field of
cataract and refractive surgery.
The Cataract and Refractive Imaging Platform is currently under development and not for sale yet.
Cataract Refractive Imaging Platform
Swept-Source OCT Technology
All measurements and analysis are based on high-resolution diagnostic images
High confidence in measurements
The Cataract and Refractive Imaging Platform is currently under development and not for sale yet.
Modular Platform
Biometry for IOL calculation Corneal topography/tomography Anterior segment biometry Anterior segment imaging
All in one device
All based on swept-source OCT
The Cataract and Refractive Imaging Platform is currently under development and not for sale yet.
Workflow OptimizationCurrent challenge
Heidelberg Engineering solution
The Cataract and Refractive Imaging Platform is currently under development and not for sale yet.
Image Management and Device Integration
The Cataract and Refractive Imaging Platform is currently under development and not for sale yet.
SPECTRALIS OCT on Board ISS
THANK YOU!
DIAGNOSTICS-IMPACT ON THE PREMIUM CHANNEL: PANEL DISCUSSION
Richard Lindstrom, MD
Moderated By:
Tom FrinziPresident – AMO
SVP – Abbott Laboratories
Participants:
Dave HarmonPresident
Market Scope
Warren Hill, MD
Ludwin Monz, PhDPresident & CEO
Carl Zeiss Meditec AG
Jay Pepose, MD, PhD Vance Thompson, MD
How important are preoperative diagnostics in managing the
premium channel IOL patients?
How large is the market opportunity in preoperative diagnostics.
Are there significant unmet needsin this arena?
Are you seeing significant investment occurring by industry,
including your own company, to meet these unmet needs.
Can one get a good return on investment in diagnostic equipment.
If time: Do you see a need in the future
for companies to pair diagnostics with therapeutics as a package
offering?